Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-escalated IMRT radiotherapy with synchronous cetuximab for intermediate-stage head and neck cancer
2007-000741-36Phase 2Terminated
- Sponsor
- The Christie
- Start
- Mar 2007
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cetuximab in head and neck squamous cell carcinoma (HNSCC), sponsored by The Christie. Started Mar 2007; status: terminated.
02
Drugs
cetuximab
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on 2007-000741-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000741-36.